Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Metastatic Breast Cancer Treatment
December 16, 2025
Enhertu (Trastuzumab Deruxtecan) Treatment of HER2+ Breast Cancer
Dr. C H Weaver MD
November 17, 2023
Truqap (capivasertib) in Breast Cancer
Dr. C H Weaver MD
February 4, 2023
Trodelvy for HR+/HER2– Metastatic Breast Cancer
Dr. C H Weaver MD
February 3, 2022
Personalized Immunotherapy for Advanced Breast Cancer with TILS
Dr. C H Weaver MD
February 21, 2021
PARP Inhibitors Slow Spread of Breast Cancer Caused by Inherited BRCA Mutations
Dr. C H Weaver MD
December 30, 2020
Ibrance Precision Cancer Medicine for Hormone Receptor Positive Breast Cancer
Dr. C H Weaver MD
December 12, 2020
Kisqali Improves Survival in Women with ER+ Advanced Breast Cancer
Dr. C H Weaver MD
November 13, 2020
Treatment of Stage IV – Metastatic Breast Cancer
Dr. C H Weaver MD
June 5, 2020
Tukysa (tucatinib) – HER2 Inhibitor for Treatment of Breast Cancer
Dr. C H Weaver MD
August 7, 2018
Abraxane™ Highly Effective in Metastatic Breast Cancer
Dr. C H Weaver MD
July 6, 2018
Fatigue Common Among Long-Term Survivors of Breast Cancer
Dr. C H Weaver MD
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
